Diagnostic utility and comparative immunohistochemical analysis of MITF-1 and SOX10 to distinguish melanoma in situ and actinic keratosis: A clinicopathological and immunohistochemical study of 70 cases

American Journal of Dermatopathology

Volumn 36, Issue 2, 2014, Pages 124-130

  Buonaccorsi, J Noelle ^a   Prieto, Victor G ^b   Torres Cabala, Carlos ^b   Suster, Saul ^a   Plaza, Jose A ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Immunohistochemistry melanoma in situ; MIFT 1; SOX10

Indexed keywords

FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KERATOSIS, ACTINIC; MALE; MELANOMA; MICROPHTHALMIA-ASSOCIATED TRANSCRIPTION FACTOR; MIDDLE AGED; RETROSPECTIVE STUDIES; SKIN NEOPLASMS; SOXE TRANSCRIPTION FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 84894535085     PISSN: 01931091     EISSN: 15330311     Source Type: Journal    
DOI: 10.1097/DAD.0b013e318291485c     Document Type: Article

References (18)

1. Beltraminelli H, Shabrawi-Caelen LE, Kerl H, et al. Melan-A- positive"pseudomelanocytic nests": A pitfall in the histopathologic and immunohistochemical diagnosis of pigmented lesions on sun-damaged skin. Am J Dermatopathol. 2009;31:305-308
2. Maize JC Jr, Resneck JS Jr, Shapiro PE, et al. Ducking stray "magic bullets": A Melan-A alert. Am J Dermatopathol. 2003;25:162-165
3. El Shabrawi-Caelen L, Kerl H, Cerroni L. Melan-A: Not a helpful marker in distinction between melanoma in situ on sun-damaged skin and pigmented actinic keratosis. Am J Dermatopathol. 2004;26:364-366
4. Hillesheim PB, Slone S, Kelley D, et al. An immunohistochemical comparison between MiTF and MART-1 with Azure blue counterstaining in the setting of solar lentigo and melanoma in situ. J Cutan Pathol. 2011; 38:565-569
5. O'Reilly FM, Brat DJ, McAlpine BE, et al. Microphthalmia transcription factor immunohistochemistry: A useful diagnostic marker in the diagnosis and detection of cutaneous melanoma, sentinel lymph node metastases, and extracutaneous melanocytic neoplasms. J Am Acad Dermatol. 2001; 45:414-419
6. Agnarsdottir M, Sooman L, Bolander A, et al. SOX10 expression in superficial spreading and nodular malignant melanomas. Melanoma Res. 2010;20:468-478
7. Nonaka D, Chiriboga L, Rubin BP. Sox10: A pan-schwannian and melanocytic marker. Am J Surg Pathol. 2008;32:1291-1298
8. Kim J, Taube JM, McCalmont TH, et al. Quantitative comparison of MiTF, Melan-A, HMB-45 and Mel-5 in solar lentigines and melanoma in situ. J Cutan Pathol. 2011;38:775-779
9. Black WH, Thareja SK, Blake BP, et al. Distinction of melanoma in situ from solar lentigo on sun-damaged skin using morphometrics and MITF immunohistochemistry. Am J Dermatopathol. 2011;33:573-578
10. Ohsie SJ, Sarantopoulos GP, Cochran AJ, et al. Immunohistochemical characteristics of melanoma. J Cutan Pathol. 2008;35:433-444
11. Busam KJ. The use and application of special techniques in assessing melanocytic tumours. Pathology. 2004;36:462-469
12. Yan S, Brennick JB. False-positive rate of the immunoperoxidase stains for MART1/MelanA in lymph nodes. Am J Surg Pathol. 2004;28: 596-600
13. Nybakken GE, Sargen M, Abraham R, et al. MITF accurately highlights epidermal melanocytes in atypical intraepidermal melanocytic proliferations. Am J Dermatopathol. 2013;35:25-29
14. Ramos-Herberth FI, Karamchandani J, Kim J, et al. SOX10 immunostaining distinguishes desmoplastic melanoma from excision scar. J Cutan Pathol. 2010;37:944-952
15. King R, Weilbaecher KN, McGill G, et al. Microphthalmia transcription factor. A sensitive and specific melanocyte marker for melanoma diagnosis. Am J Pathol. 1999;155:731-738
16. King R, Googe PB, Weilbaecher KN, et al. Microphthalmia transcription factor expression in cutaneous benign, malignant melanocytic, and nonmelanocytic tumors. Am J Surg Pathol. 2001;25:51-57
17. Busam KJ, Iversen K, Coplan KC, et al. Analysis of microphthalmia transcription factor expression in normal tissues and tumors, and comparison of its expression with S-100 protein, gp100, and tyrosinase in desmoplastic malignant melanoma. Am J Surg Pathol. 2001;25:197-204
18. Miettinen M, Fernandez M, Franssila K, et al. Microphthalmia transcription factor in the immunohistochemical diagnosis of metastatic melanoma: Comparison with four other melanoma markers. Am J Surg Pathol. 2001;25:205-211